Australia's largest stock trading and investment forum Australia's #1 stock forum

Research Reports, page-513

First 513 Last

Share
Profile

Follow
hazyg

4,560 Posts.

163

29/12/20

15:58

Post #: 49848492
Share

Originally posted by Greenenergy: ↑

Exciting times for Novonix, with Puregraphite anode plant going live this week.

We cannot wait to see Commercial Production, Finished Puregraphite anode material rolling off the line and being trucked and or trained to EV battery makers.

Let alone thecashflow rolling in!

Novonix's Battery Testing & Technology division is already expected to generate $A4-5million in FY 2020, but it is the Puregraphite anode material that will generate strong and growing profits once Commercial Production Commences and in time, Dividends for us shareholders.

There aren't many companies on the ASX that can match these profits and Discounted Future Cashflows.

Below are some of my calculations on Novonix's PUREgraphite profits in $A based on announcements made by the company of $US3k per tonne processing cost and $US8k-$20k per tonne sales revenues.

We’ll get a better picture of how much profit they will be generating as they announce production levels and as new EV battery maker supply agreements are signed.

Expand

what was the planned production capacity?
Upvote

0 Great analysis

Reply

Top Stories

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 513 Last

SPONSORED BY